angiotensin ii has been researched along with Hypercholesterolemia in 83 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (3.61) | 18.7374 |
1990's | 10 (12.05) | 18.2507 |
2000's | 31 (37.35) | 29.6817 |
2010's | 36 (43.37) | 24.3611 |
2020's | 3 (3.61) | 2.80 |
Authors | Studies |
---|---|
Cassis, LA; Daugherty, A; Lu (吕红), HS; Sawada (澤田悠), H | 1 |
Chao de la Barca, JM; Eid, M; Fassot, C; Faure, J; Fouquet, O; Henrion, D; Loufrani, L; Reynier, P; Richard, A; Robert, P; Tessier, L; Wetterwald, C | 1 |
Autieri, MV; Corbett, CB; Okune, R; St Paul, A | 1 |
Buszman, E; Jasik, K; Rzepecka-Stojko, A; Stojko, J | 1 |
Folestad, E; Länne, T; Rossignoli, A; Skogberg, J; Vorkapic, E; Wågsäter, D; Wanhainen, A | 1 |
Chen, WQ; Cui, GH; Shen, ZY | 1 |
Balakrishnan, A; Danser, AHJ; Daugherty, A; Graham, MJ; Howatt, DA; Lu, HS; Mullick, AE; Wang, J; Wang, Y; Wu, C; Wu, CH; Ye, F | 1 |
Cheng, X; Dong, Y; Li, J; Long, H; Peng, Q; Su, H; Wang, L; Xu, J | 1 |
Badimon, L; Casani, L; Lugano, R; Padró, T; Peña, E | 1 |
Cassis, LA; Chen, X; Daugherty, A; Lu, H; Tashiro, K; Zhao, M | 1 |
Bullen, ML; Drummond, GR; Kemp-Harper, BK; Moore, JP; Ricardo, SD; Sakkal, S; Sobey, CG | 1 |
Hazama, A; Katsuda, S; Kojima, I; Miyashita, H; Miyawaki, Y; Shimada, K; Shiogai, Y | 1 |
Conway, V; Couture, P; Gauthier, S; Lamarche, B; Pouliot, Y | 1 |
Airey, D; F Linton, M; Fazio, S; Hill, MF; Kon, V; Nwosu, S; Perati, PR; Prins, PA; Sampson, UK; Tavori, H | 1 |
Ferrario, CM; Guenther, K; Haufe, S; Hermann, C; Jordan, J; Kirch, W; Schindler, C; Schroeder, C | 1 |
Cassis, LA; Curci, JA; Daugherty, A; Ennis, T; Gurley, SB; Howatt, DA; Thatcher, SE; Yiannikouris, F; Zhang, X | 1 |
Ailawadi, G; Bhamidipati, CM; Hajzus, VA; Meher, AK; Mehta, GS; Owens, GK; Salmon, M; Su, G; Upchurch, GR; Whatling, CA | 1 |
Ait-Oufella, H; Esposito, B; Loyer, X; Mallat, Z; Mellak, S; Poirier, M; Potteaux, S; Tedder, TF; Tedgui, A | 1 |
Chen, JW; Chen, Z; Chien, S; Fang, L; Geary, GG; Geary, MJ; Hsu, CY; Huang, HD; Huang, PH; Johnson, DA; Lin, FM; Lin, SJ; Lin, TY; Martin, M; Miller, YI; Shyy, JY; Wen, L; Zhao, Y | 1 |
Balakrishnan, A; Cassis, LA; Daugherty, A; Howatt, DA; Liu, J; Lu, H; Moorleghen, JJ; Sorci-Thomas, M | 1 |
Balakrishnan, A; Cassis, LA; Daugherty, A; Howatt, DA; Lu, H; Moorleghen, JJ; Rateri, DL | 1 |
Granger, DN; Senchenkova, E; Yildirim, A | 1 |
Balakrishnan, A; Daugherty, A; Graham, MJ; Howatt, DA; Lu, H; Mullick, AE | 1 |
Cassis, LA; Charnigo, R; Daugherty, A; Gupte, M; Howatt, DA; Rateri, DL; Thayer, S; Zhang, X | 1 |
Cockerill, GW; Deb, R; Dunkley, M; Gaze, D; Gnaneswaran, Y; Howe, F; Jones, A; Loftus, IM; Nasr, H; Thompson, MM; Torsney, E | 1 |
Ahishali, B; Arican, N; Bilgic, B; Elmas, I; Kalayci, R; Kaya, M; Küçük, M; Uzun, H | 1 |
Hu, D; Li, Y; Liu, N; Ren, L; Sheng, Z; Tang, R | 1 |
Cassis, LA; Charo, IF; Daugherty, A; Howatt, DA; Owens, AP; Rateri, DL | 1 |
Gopal, K; Jahan, P; Kumar, K; Kumar, MJ; Nandini, R | 1 |
Jerez, S; Peral de Bruno, M; Scacchi, F; Sierra, L | 1 |
Cassis, LA; Charnigo, R; Daugherty, A; Kristo, F; Lu, H; Rateri, DL; Uchida, HA | 1 |
Asselin, C; Bouly, M; Brand, G; Busseuil, D; Des Rosiers, C; Gillis, MA; Latour, JG; Leung, TK; Mecteau, M; Rhéaume, E; Roméo, P; Shi, Y; Tardif, JC; Thorin, E | 1 |
Hayashi, S; Hazama, A; Katsuda, S; Kusanagi, M; Murakawa, M; Obara, S | 1 |
Li, Y; Liu, N; Ren, L; Sheng, Z; Tang, R; Zhi, H | 1 |
Fu, X; He, SW; Huang, HW; Lin, RJ; Peng, DX; Su, LL; Tan, SQ; Wong, KS | 1 |
Cassis, LA; Daugherty, A; Lu, H | 1 |
Cassis, LA; Daugherty, A; Poduri, A; Subramanian, V; Uchida, HA | 1 |
Balakrishnan, A; Howatt, DA; Ijaz, T; Moorleghen, JJ; Subramanian, V; Uchida, HA | 1 |
Balakrishnan, A; Cassis, LA; Charnigo, R; Daugherty, A; Howatt, DA; Liau, G; Lu, H; Wu, C | 1 |
Cassis, LA; Charnigo, R; Daugherty, A; Howatt, DA; Lu, H; Moorleghen, JJ; Subramanian, V; Wang, S | 1 |
Baxter, BT; Charolidi, N; Cockerill, GW; Gaze, D; Laing, K; Meisinger, T; Petrova, S; Pirianov, G; Shoreim, A; Torsney, E; Xiong, W | 1 |
Granger, DN; Rodrigues, SF; Vital, SA | 1 |
Böhm, M; Hilgers, S; Laufs, U; Nickenig, G; Wassmann, S | 1 |
Siegel-Axel, DI | 1 |
Fujimura, A; Sugimoto, K | 1 |
Egashira, K; Hirouchi, Y; Inoue, S; Kitajima, S; Kitamoto, S; Kohjimoto, Y; Nakano, K; Usui, M | 1 |
Aubert, JF; Bouzourene, K; Brunner, HR; Duchosal, MA; Gabbiani, G; Hao, H; Hayoz, D; Korber, M; Mazzolai, L; Nussberger, J; Vallet, V | 1 |
Forrest, ST; McNamara, CA; Perlegas, D; Sarembock, IJ; Taylor, AM | 1 |
Dick, JB; Sim, JS; Struthers, AD | 1 |
Cassis, LA; Daugherty, A; Inagami, T; Lu, H; Rateri, DL | 1 |
Delles, C; Fleischmann, EH; John, S; Schmidt, BM; Schmieder, RE; Schneider, MP | 1 |
Wang, YX | 1 |
Fóris, G; Kosztáczky, B; Páll, D; Paragh, G; Seres, I; Varga, Z | 1 |
da Cunha, V; Martin-McNulty, B; Rutledge, JC; Sullivan, ME; Vergona, R; Vincelette, J; Wang, YX; Wilson, DW; Zhang, L | 1 |
Gitlin, JM; King, VL; Loftin, CD; Trivedi, DB | 1 |
Nickenig, G; Wassmann, S | 1 |
Boomsma, F; Sijbrands, EJ; van den Meiracker, AH; van der Linde, NA | 1 |
Balogh, Z; Fóris, G; Fülöp, P; Kassai, A; Kosztáczky, B; Paragh, G; Seres, I; Varga, Z | 1 |
Ferrario, CM; Strawn, WB | 1 |
Ishikawa, K; Kamiyama, Y; Kimura, S; Kobayashi, A; Maruyama, Y; Matsumoto, H | 1 |
Blanco-Colio, LM; Egido, J; Martín-Ventura, JL; Tarín, N; Tuñón, J | 1 |
Coviello, A; de Bruno, MP; Jerez, S; Sierra, L | 1 |
Cassis, LA; Daugherty, A; King, VL | 1 |
Atkins, AR; Barish, GD; Collins, AR; Downes, M; Evans, RM; Hsueh, WA; Lee, CH; Liu, J; Lyon, CJ; Takata, Y; Tangirala, RK; Yin, F | 1 |
Lo, YK; Plante, GE; Sirois, P | 1 |
Howes, LG; Lam, W; Louis, WJ; Straznicky, NE | 1 |
Böhm, M; Jung, O; Linz, W; Nickenig, G; Schölkens, BA; Strehlow, K; Zolk, O | 1 |
Dam, JP; Porsius, AJ; Post, MJ; Riezebos, J; Vleeming, W; Wemer, J | 1 |
Choi, Y; Choo, JA; Gwon, HC; Huh, JE; Kim, DK; Kim, JW; Kim, S; Lee, WR; Rhee, CH; Ryu, JC | 1 |
el-Sherbeeny, M; Khayyal, MA; Khayyal, MT; Okpanyi, SN; Schneider, W; Sharaf, HM | 1 |
Mehta, JL; Mehta, P; Meng, H; Mohuczy, D; Phillips, MI; Shen, L; Yang, BC | 1 |
Pratt, RE | 1 |
Masana Marín, L; Valero Capilla, FA | 1 |
Arakawa, K; Ideishi, M; Kimura, M; Sakata, N; Sasaguri, M; Tashiro, T; Uehara, Y; Urata, H | 1 |
Aviram, M; Hayek, T; Heinrich, R; Keidar, S; Sakhnini, E | 1 |
Hasegawa, J; Kawasaki, H; Kishimoto, Y; Kitano, M; Morisawa, T | 1 |
Cooke, JP; Lin, PS; Niebauer, J; Pratt, RE; Tsao, PS | 1 |
Chen, H; Li, D; Mehta, JL | 1 |
Balogh, Z; Fóris, G; Kárpáti, I; Keresztes, T; Kovács, E; Páll, D; Paragh, G; Szabó, J | 1 |
Bilder, GE; Merkel, LA; Perrone, MH; Rivera, LM | 1 |
Kawaguchi, H; Takahashi, K; Yasuda, H | 1 |
Takahashi, K | 1 |
Freyss-Beguin, M; Mathieu-Levy, N; van Brussel, E | 1 |
8 review(s) available for angiotensin ii and Hypercholesterolemia
Article | Year |
---|---|
Twenty Years of Studying AngII (Angiotensin II)-Induced Abdominal Aortic Pathologies in Mice: Continuing Questions and Challenges to Provide Insight Into the Human Disease.
Topics: Age Factors; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Blood Pressure; Disease Models, Animal; Female; Heart Disease Risk Factors; Humans; Hypercholesterolemia; Male; Mice; Mice, Transgenic; Models, Cardiovascular; Receptors, Angiotensin; Sex Factors | 2022 |
Angiotensin II, Hypercholesterolemia, and Vascular Smooth Muscle Cells: A Perfect Trio for Vascular Pathology.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Cells, Cultured; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Signal Transduction | 2020 |
Complex pathologies of angiotensin II-induced abdominal aortic aneurysms.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Connective Tissue; Disease Models, Animal; Disease Progression; Female; Humans; Hypercholesterolemia; Male; Mice; Peptides; Renin-Angiotensin System; Time Factors | 2011 |
Cerivastatin: a cellular and molecular drug for the future?
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Arteriosclerosis; Endothelium, Vascular; Epoprostenol; Extracellular Matrix; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Monocytes; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Pyridines; Receptors, Angiotensin; Thrombosis | 2003 |
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cardiac Output, High; Cardiomegaly; Cardiovascular System; Enzyme Inhibitors; Estradiol; Hypercholesterolemia; Hyperglycemia; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Phenotype; Simvastatin | 2005 |
Pathophysiological regulation of the AT1-receptor and implications for vascular disease.
Topics: Angiotensin II; Atherosclerosis; Diabetes Complications; Estrogens; Humans; Hypercholesterolemia; Interleukin-6; Receptor, Angiotensin, Type 1 | 2006 |
Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors.
Topics: Angiotensin II; Cardiovascular Diseases; Humans; Hypercholesterolemia; Hypertension; Risk Factors; Thrombosis | 2007 |
Angiotensin II and the control of cardiovascular structure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Coronary Artery Disease; Coronary Vessels; Humans; Hypercholesterolemia; Macrophages; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Receptors, Angiotensin | 1999 |
10 trial(s) available for angiotensin ii and Hypercholesterolemia
Article | Year |
---|---|
Effect of buttermilk consumption on blood pressure in moderately hypercholesterolemic men and women.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Cholesterol, LDL; Cross-Over Studies; Cultured Milk Products; Double-Blind Method; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Young Adult | 2014 |
Statin treatment in hypercholesterolemic men does not attenuate angiotensin II-induced venoconstriction.
Topics: Angiotensin II; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Vasoconstriction; Veins | 2014 |
Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Cholesterol, LDL; Double-Blind Method; Endothelium, Vascular; Felodipine; Female; Forearm; Humans; Hypercholesterolemia; Inflammation; Male; Middle Aged; Prospective Studies; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Regional Blood Flow; Tetrazoles | 2002 |
Different effects of simvastatin and pravastatin on adrenal sensitivity to angiotensin II.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Cross-Over Studies; Diuretics; Female; Furosemide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Simvastatin | 2003 |
Statin therapy increases vascular sensitivity to angiotensin II in hypercholesterolaemic patients.
Topics: Angiotensin I; Angiotensin II; Brachial Artery; Cholesterol; Cross-Over Studies; Double-Blind Method; Female; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Norepinephrine; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents | 2004 |
The effect of statins on angiotensin II-induced hemodynamic changes in young, mildly hypercholesterolemic men.
Topics: Adolescent; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Dose-Response Relationship, Drug; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pyridines; Severity of Illness Index; Tetrazoles; Triglycerides; Vascular Resistance; Vasoconstrictor Agents | 2004 |
Angiotensin II-induced oxidative burst is fluvastatin sensitive in neutrophils of patients with hypercholesterolemia.
Topics: Aged; Angiotensin II; Calcium; Cells, Cultured; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Leukotriene C4; Male; Membrane Fluidity; Middle Aged; Neutrophils; Reactive Oxygen Species; Respiratory Burst; Signal Transduction; Vasoconstrictor Agents | 2005 |
Effect of low-density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin.
Topics: Adult; Angiotensin II; Anticholesteremic Agents; Blood Pressure; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Male; Norepinephrine; Vasoconstrictor Agents | 2006 |
Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension.
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Cardiovascular System; Cholesterol; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Norepinephrine; Pravastatin; Treatment Outcome | 1995 |
Influence of angiotensin II type 1 receptor polymorphism on hypertension in patients with hypercholesterolemia.
Topics: Aged; Alleles; Angiotensin II; Base Sequence; DNA Primers; Female; Gene Frequency; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Receptors, Angiotensin | 2001 |
65 other study(ies) available for angiotensin ii and Hypercholesterolemia
Article | Year |
---|---|
Metabolomic Profiling of Angiotensin-II-Induced Abdominal Aortic Aneurysm in Ldlr
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Disease Models, Animal; Energy Metabolism; Glutamine; Glycine; Hypercholesterolemia; Hyperlipidemias; Lipids; Metabolomics; Mice; Mice, Inbred C57BL; Nitric Oxide; Receptors, LDL | 2022 |
Anti-Atherogenic Activity of Polyphenol-Rich Extract from Bee Pollen.
Topics: Angiotensin II; Animals; Arginine; Atherosclerosis; Bees; Cholesterol; Coronary Artery Disease; Diet, High-Fat; Dose-Response Relationship, Drug; Female; Hypercholesterolemia; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Peptidyl-Dipeptidase A; Pollen; Polyphenols | 2017 |
Plasma cholesterol lowering in an AngII‑infused atherosclerotic mouse model with moderate hypercholesterolemia.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoprotein B-100; Atherosclerosis; Cholesterol; Disease Models, Animal; Gene Expression Regulation; Hypercholesterolemia; Integrases; Male; Receptors, LDL | 2018 |
Urolithin A shows anti-atherosclerotic activity via activation of class B scavenger receptor and activation of Nef2 signaling pathway.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; CD36 Antigens; Coumarins; Hypercholesterolemia; Lipids; Male; MAP Kinase Signaling System; NF-E2-Related Factor 2; Rats; Rats, Wistar; Receptors, Scavenger; Signal Transduction; Up-Regulation | 2018 |
Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report.
Topics: Angiotensin II; Angiotensinogen; Animals; Atherosclerosis; Female; Hypercholesterolemia; Low Density Lipoprotein Receptor-Related Protein-2; Male; Mice; Mice, Inbred C57BL; Oligonucleotides, Antisense; Renin-Angiotensin System | 2019 |
Increased circulatory RAS activity can be inhibited by statins in patients with hypercholesterolemia.
Topics: Angiotensin II; Blood Pressure; Cholesterol; Electrocardiography; Female; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Triglycerides | 2015 |
UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1.
Topics: Angiotensin II; Animals; Cell Movement; Cells, Cultured; Humans; Hypercholesterolemia; Lipoproteins, LDL; Low Density Lipoprotein Receptor-Related Protein-1; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Receptors, Urokinase Plasminogen Activator; Urokinase-Type Plasminogen Activator; Wound Healing | 2013 |
Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atherosclerosis; Bone Marrow Transplantation; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Enalapril; Hypercholesterolemia; Leukocytes; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptidyl-Dipeptidase A; Receptors, LDL; Transplantation Chimera | 2013 |
A flow cytometric method for the analysis of macrophages in the vascular wall.
Topics: Angiotensin II; Animals; Antigens, Differentiation; Aorta; Apolipoproteins E; Cells, Cultured; Flow Cytometry; Fluorescent Dyes; Hypercholesterolemia; Hypertension; Leukocyte Common Antigens; Macrophages; Male; Mice; Mice, Inbred C57BL | 2013 |
Subservient relationship of the peripheral second systolic pressure peak to the central hemodynamic parameters is preserved, irrespective of atherosclerosis progression in hypercholesterolemic rabbits.
Topics: Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Disease Progression; Hemodynamics; Hypercholesterolemia; Hypertension; Male; Nitroprusside; Rabbits; Vasoconstrictor Agents; Vasodilator Agents | 2014 |
Angiotensin-induced abdominal aortic aneurysms in hypercholesterolemic mice: role of serum cholesterol and temporal effects of exposure.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Cholesterol; Elastin; Hypercholesterolemia; Macrophages; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Time Factors; Ultrasonography | 2014 |
Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aortic Aneurysm, Abdominal; Diminazene; Disease Models, Animal; Enzyme Activation; Female; Humans; Hypercholesterolemia; Leukocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Peptidyl-Dipeptidase A; Receptors, LDL; Renin-Angiotensin System; RNA, Messenger | 2014 |
5-Lipoxygenase pathway in experimental abdominal aortic aneurysms.
Topics: Aged; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Arachidonate 5-Lipoxygenase; Bone Marrow Transplantation; Disease Models, Animal; Disease Progression; Humans; Hypercholesterolemia; Lipoxygenase Inhibitors; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Neutrophil Infiltration; Pancreatic Elastase; Receptors, LDL; Signal Transduction; Transplantation Chimera | 2014 |
Angiotensin II mobilizes spleen monocytes to promote the development of abdominal aortic aneurysm in Apoe-/- mice.
Topics: Angiotensin II; Animals; Antigens, Ly; Aortic Aneurysm, Abdominal; Apolipoproteins E; B-Lymphocytes; Bone Marrow Transplantation; Cell Movement; Cells, Cultured; Disease Models, Animal; DNA-Binding Proteins; Hypercholesterolemia; Male; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Spleen; Splenectomy; Time Factors | 2015 |
Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a.
Topics: Aged; Angiotensin II; Animals; Coronary Disease; Endothelial Cells; Endothelium, Vascular; Female; Free Radical Scavengers; Gene Expression Regulation; Genes, Reporter; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Hypercholesterolemia; Immunity, Innate; Inflammasomes; Interleukin-1beta; Kruppel-Like Factor 4; Lipoproteins, LDL; Male; Mice; Mice, Transgenic; MicroRNAs; Middle Aged; Organometallic Compounds; Oxidative Stress; Recombinant Fusion Proteins; Salicylates; Sterol Regulatory Element Binding Protein 2; Transcriptional Activation; Zebrafish; Zebrafish Proteins | 2015 |
Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice.
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoprotein A-I; Apolipoprotein B-100; Apolipoproteins B; Apolipoproteins E; Azetidines; Diet, Western; Disease Models, Animal; Ezetimibe; Female; Hypercholesterolemia; Male; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; Sex Factors | 2015 |
Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Apolipoproteins E; Disease Models, Animal; Female; Humans; Hypercholesterolemia; Infusion Pumps, Implantable; Male; Mice; Mice, Transgenic | 2015 |
Hypercholesterolemia blunts the oxidative stress elicited by hypertension in venules through angiotensin II type-2 receptors.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Apolipoproteins E; Cell Adhesion; Chemotaxis, Leukocyte; Cholesterol, Dietary; Disease Models, Animal; Hypercholesterolemia; Hypertension; Leukocytes; Male; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Receptor, Angiotensin, Type 2; Signal Transduction; Venules | 2016 |
Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Biomarkers; Cholesterol; Dependovirus; Disease Models, Animal; Gene Transfer Techniques; Genetic Predisposition to Disease; Genetic Vectors; Hypercholesterolemia; Male; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Mutation; Oligonucleotides, Antisense; Proprotein Convertase 9; Receptors, LDL; Species Specificity; Time Factors | 2016 |
ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Blood Pressure; Cholesterol, Dietary; Disease Models, Animal; Hydralazine; Hypercholesterolemia; Hypertension; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Norepinephrine; Receptors, LDL; Risk Factors; Time Factors | 2009 |
Rosiglitazone reduces the development and rupture of experimental aortic aneurysms.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Aortic Rupture; Apolipoproteins E; Blood Glucose; Body Weight; Cholesterol; Disease Models, Animal; E-Selectin; Humans; Hypercholesterolemia; Hypoglycemic Agents; Interleukin-6; Mice; Mice, Knockout; PPAR gamma; Receptors, Angiotensin; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2009 |
Influence of hypercholesterolemia and hypertension on the integrity of the blood-brain barrier in rats.
Topics: Analysis of Variance; Angiotensin II; Animals; Blood-Brain Barrier; Body Weight; Catalase; Cholesterol; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glutathione; Hypercholesterolemia; Hypertension; Lipoproteins, LDL; Male; Malondialdehyde; Membrane Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphoproteins; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Zonula Occludens-1 Protein | 2009 |
The inhibitory effects of rosiglitazone on cardiac hypertrophy through modulating the renin-angiotensin system in diet-induced hypercholesterolemic rats.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Cardiomegaly; Cholesterol, Dietary; Hypercholesterolemia; Irbesartan; Male; Myocardium; PPAR gamma; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Rosiglitazone; Tetrazoles; Thiazolidinediones | 2010 |
Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Apolipoproteins E; Blood Pressure; Body Weight; Cholesterol; Disease Models, Animal; Hypercholesterolemia; Lipids; Male; Mice; Mice, Knockout; Receptors, CCR2; Vasodilation | 2010 |
High fat diet containing cholesterol induce aortic aneurysm through recruitment and proliferation of circulating agranulocytes in apoE knock out mice model.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Apolipoproteins E; Biomarkers; Blood Pressure; Cell Movement; Cell Proliferation; Chemokine CCL2; Cholesterol, Dietary; Disease Models, Animal; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation; Granulocytes; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Mice, Knockout; Time Factors; Vascular Cell Adhesion Molecule-1; Weight Gain | 2010 |
Hypercholesterolemia modifies angiotensin II desensitisation and cross talk between alpha(1)-adrenoceptor and angiotensin AT(1) receptor in rabbit aorta.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blood Pressure; Dietary Fats; Homeostasis; Hypercholesterolemia; In Vitro Techniques; Male; Membrane Potentials; Muscle, Smooth; Norepinephrine; Rabbits; Receptor Cross-Talk; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha-1; Rest; Vasoconstriction | 2010 |
Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice.
Topics: Aneurysm; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; B-Lymphocytes; Female; Gene Expression Regulation; Genotype; Hypercholesterolemia; Lymphocytes; Male; Mice; T-Lymphocytes | 2010 |
Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis.
Topics: Aldosterone; Angiotensin II; Animals; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Diastole; Echocardiography, Doppler, Pulsed; Fibrosis; Heart Atria; Heart Rate; Heart Ventricles; Hemodynamics; Hypercholesterolemia; Ivabradine; Oxidative Stress; Rabbits; Sinoatrial Node; Ventricular Dysfunction, Left | 2010 |
To what extent does aortic pulse wave velocity estimate early atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic rabbits?
Topics: Angiotensin II; Animals; Aorta, Abdominal; Atherosclerosis; Blood Pressure; Hypercholesterolemia; Male; Nitroprusside; Pulsatile Flow; Rabbits; Ultrasonography; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2011 |
Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.
Topics: Angiotensin II; Animals; Aortic Diseases; Atherosclerosis; Blotting, Western; Cardiovascular Agents; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Hypercholesterolemia; Immunohistochemistry; Lipids; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Radioimmunoassay; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors | 2011 |
Influence of angiotensin-converting enzyme insertion/deletion polymorphism on nitric oxide production in hypertensives and hypercholesterolaemics.
Topics: Adult; Alleles; Angiotensin II; Arginine; Base Sequence; Blood Pressure; China; Female; Gene Deletion; Genotype; Humans; Hypercholesterolemia; Hypertension; INDEL Mutation; Male; Nitric Oxide; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Vasodilation | 2011 |
Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms.
Topics: Aneurysm, Ruptured; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Bone Marrow Cells; Disease Models, Animal; Hypercholesterolemia; Incidence; Leukocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; Receptors, Urokinase Plasminogen Activator; Urokinase-Type Plasminogen Activator | 2011 |
Calpain inhibition attenuates angiotensin II-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; Blotting, Western; Calpain; Cysteine Proteinase Inhibitors; Diet, High-Fat; Disease Models, Animal; Hypercholesterolemia; Male; Mice; Mice, Knockout; Receptors, LDL; Sulfonamides | 2012 |
Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.
Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Atherosclerosis; Blood Pressure; Cholesterol; Diet, High-Fat; Enalapril; Fumarates; Hypercholesterolemia; Kidney; Losartan; Male; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptors, LDL; Renin; Renin-Angiotensin System | 2012 |
Deficiency of receptor-associated protein attenuates angiotensin II-induced atherosclerosis in hypercholesterolemic mice without influencing abdominal aortic aneurysms.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; Bone Marrow Cells; Bone Marrow Transplantation; Cells, Cultured; Cholesterol; Disease Models, Animal; Hypercholesterolemia; LDL-Receptor Related Protein-Associated Protein; Low Density Lipoprotein Receptor-Related Protein-1; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptors, LDL; Tumor Suppressor Proteins | 2012 |
Elevation of plasma high-density lipoproteins inhibits development of experimental abdominal aortic aneurysms.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Aortic Rupture; Apolipoproteins E; Autophagy; Calcium Chloride; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Hypercholesterolemia; Injections, Subcutaneous; JNK Mitogen-Activated Protein Kinases; Lipoproteins, HDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oligonucleotide Array Sequence Analysis; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Time Factors; Up-Regulation | 2012 |
Mild hypercholesterolemia blunts the proinflammatory and prothrombotic effects of hypertension on the cerebral microcirculation.
Topics: Angiotensin II; Animals; Apolipoprotein A-I; Blood-Brain Barrier; Cerebrovascular Circulation; Disease Models, Animal; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, HDL; Male; Mice; Mice, Transgenic; Microcirculation; Vasoconstrictor Agents; Venules | 2013 |
Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aorta, Abdominal; Aortic Diseases; Arteriosclerosis; Catheterization; Chemokine CCL2; Chemotaxis; Cholesterol; Cytokines; Diet, Atherogenic; DNA, Complementary; Drug Evaluation, Preclinical; Genetic Therapy; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iliac Artery; Immunoglobulin G; Immunoglobulin M; Inflammation; Macaca fascicularis; Male; Peptidyl-Dipeptidase A; Phenotype; Pravastatin; Random Allocation; Renin; Transfection | 2004 |
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Coronary Artery Disease; Fibrosis; Hypercholesterolemia; Hypertension, Renovascular; Ligation; Mice; Mice, Knockout; Nephrectomy; Renal Artery; Renin; Renin-Angiotensin System; Rupture, Spontaneous; Th1 Cells; Th2 Cells; Vasculitis | 2004 |
Phosphorylation regulates Id3 function in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Becaplermin; Cell Cycle Proteins; Cell Division; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Gene Expression Regulation; Humans; Hypercholesterolemia; Inhibitor of Differentiation Proteins; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Phosphorylation; Platelet-Derived Growth Factor; Protein Processing, Post-Translational; Proteins; Proto-Oncogene Proteins c-sis; Rats; Recombinant Fusion Proteins; Transcription Factors; Transfection | 2004 |
Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin III; Angiotensinogen; Animals; Aortic Diseases; Arteriosclerosis; Chemokine CCL2; Chickens; Diet, Atherogenic; Female; Hypercholesterolemia; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, LDL; Renin-Angiotensin System; RNA, Messenger | 2004 |
Interaction between mild hypercholesterolemia, HDL-cholesterol levels, and angiotensin II in intimal hyperplasia in mice.
Topics: Angiotensin II; Animals; Carotid Arteries; Cholesterol, HDL; Diet; Hypercholesterolemia; Hyperplasia; Immunohistochemistry; Lipid Metabolism; Mice; Mice, Inbred C57BL | 2006 |
Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Hypercholesterolemia; Male; Mice; Mice, Inbred C57BL; Prostaglandin D2; Pyrazoles; Sulfonamides | 2006 |
The association between angiotensin II-induced free radical generation and membrane fluidity in neutrophils of patients with metabolic syndrome.
Topics: Adult; Angiotensin I; Angiotensin II; Anticholesteremic Agents; Cholesterol; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Female; Fluvastatin; Homeostasis; Humans; Hypercholesterolemia; Indoles; Leukotriene C4; Male; Membrane Fluidity; Metabolic Syndrome; Middle Aged; Neutrophils; Pertussis Toxin; Protein Prenylation; Quinacrine; Signal Transduction; Superoxides; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 2006 |
Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys.
Topics: Angiotensin II; Animals; Antigens, CD34; Bone Marrow Cells; CD11b Antigen; Cholesterol; Cholesterol, Dietary; Hypercholesterolemia; Leukocytes, Mononuclear; Losartan; Macaca fascicularis; Male; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2008 |
Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II - induced cardiac hypertrophy.
Topics: Angiotensin II; Animals; Antioxidants; Aorta; Blood Pressure; Carbon Monoxide; Carboxyhemoglobin; Cardiomegaly; Hydralazine; Hypercholesterolemia; Lipid Peroxides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptors, LDL; Vasodilator Agents | 2007 |
Endothelial dysfunction and improvement of the angiotensin II-reactivity in hypercholesterolemic rabbits: role of cyclooxygenase metabolites.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Cholesterol, Dietary; Cyclooxygenase 1; Dose-Response Relationship, Drug; Electrophysiology; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Hypercholesterolemia; Male; Nitric Oxide; Rabbits; Vasoconstriction; Vasoconstrictor Agents | 2008 |
Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Female; Hypercholesterolemia; Interleukin-4; Male; Mice; Mice, Mutant Strains; Receptors, LDL | 2007 |
PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis.
Topics: Adipokines; Angiotensin II; Animals; Atherosclerosis; Cell Movement; Enzyme Activation; Gene Expression Regulation; Hypercholesterolemia; Hypertriglyceridemia; Inflammation; Ligands; Macrophages; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; PPAR delta; Proto-Oncogene Proteins c-bcl-6; Receptors, LDL; Signal Transduction; Thiazoles; Transcription, Genetic | 2008 |
[Effect of hypercholesterolemia on vascular reactivity: repercussions on renal hemodynamics in the rabbit].
Topics: Angiotensin II; Animals; Aorta; Endothelium, Vascular; Glomerular Filtration Rate; Hypercholesterolemia; Isometric Contraction; Mesenteric Arteries; Mesenteric Veins; Rabbits; Renal Circulation | 1994 |
Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression.
Topics: Angiotensin II; Animals; Cholesterol; Homeostasis; Hypercholesterolemia; Male; Rabbits; Receptors, Angiotensin; Reference Values; RNA, Messenger; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Effects of hypercholesterolemia on the contractions to angiotensin II in the isolated aorta and iliac artery of the rabbit: role of arachidonic acid metabolites.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arachidonic Acid; Cholesterol, Dietary; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Hypercholesterolemia; Iliac Artery; In Vitro Techniques; Indomethacin; Lipoxygenase Inhibitors; Male; Masoprocol; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Rabbits; Ramipril; Vasoconstrictor Agents | 1997 |
Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.
Topics: Alleles; Angiotensin II; Asian People; Comorbidity; Coronary Disease; Diabetes Mellitus; Ethnicity; Female; Genetic Variation; Genotype; Humans; Hypercholesterolemia; Hypertension; Korea; Male; Mass Screening; Middle Aged; Obesity; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Postmenopause; Risk Factors; Sequence Deletion; Sex Characteristics; Smoking | 1997 |
Effect of magnesium pyridoxal 5-phosphate glutamate on vascular reactivity in experimental hypercholesterolemia.
Topics: Acetylcholine; Angiotensin II; Animals; Blood Pressure; Cholesterol, Dietary; Clonidine; Drug Evaluation, Preclinical; Glutamine; Histamine; Hypercholesterolemia; Hypolipidemic Agents; In Vitro Techniques; Male; Norepinephrine; Pyridoxal Phosphate; Rabbits; Vasoconstrictor Agents; Vasomotor System | 1998 |
Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Arteriosclerosis; Autoradiography; Cholesterol, Dietary; Gene Expression; Hypercholesterolemia; Immunohistochemistry; Male; Norepinephrine; Polymerase Chain Reaction; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA-Directed DNA Polymerase; RNA, Messenger; Tissue Distribution | 1998 |
[Clinical characteristics and follow-up of patients attending a hospital hypertension clinic. 10-year experience].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Data Interpretation, Statistical; Diabetes Complications; Diuretics; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Obesity; Outpatients; Risk Factors; Time Factors | 1999 |
Increased chymase activity in internal thoracic artery of patients with hypercholesterolemia.
Topics: Aged; Angiotensin II; Arteriosclerosis; Cholesterol; Cholesterol, LDL; Chymases; Female; Humans; Hypercholesterolemia; Immunohistochemistry; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Serine Endopeptidases; Thoracic Arteries | 2000 |
Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Biological Transport, Active; CD36 Antigens; Gene Expression; Humans; Hypercholesterolemia; In Vitro Techniques; Lipoproteins, LDL; Losartan; Macrophages; Monocytes; Oxidation-Reduction; RNA, Messenger | 2000 |
Cholesterol-induced upregulation of angiotensin II and its effects on monocyte-endothelial interaction and superoxide production.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Aorta, Thoracic; Cell Adhesion; Cholesterol, Dietary; Endothelium, Vascular; Enzyme Inhibitors; Hypercholesterolemia; In Vitro Techniques; Male; Monocytes; Proline; Protein Kinase C; Rabbits; Reference Values; Staurosporine; Superoxides; Thiocarbamates; Up-Regulation | 2001 |
Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappa B by losartan in hypercholesterolemic rabbits.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Abdominal; Arteriosclerosis; Blotting, Western; Cholesterol; Diet, Atherogenic; Gene Expression Regulation; Hypercholesterolemia; Immunohistochemistry; Losartan; Male; Matrix Metalloproteinase 1; NF-kappa B; Rabbits; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-2; Tunica Intima; Tunica Media | 2002 |
Altered signal pathway in angiotensin II-stimulated neutrophils of patients with hypercholesterolaemia.
Topics: Angiotensin II; Calcium Signaling; Dose-Response Relationship, Drug; Humans; Hypercholesterolemia; Inositol 1,4,5-Trisphosphate; Leukotrienes; Male; Middle Aged; Neutrophils; Pertussis Toxin; Receptors, Angiotensin; Signal Transduction; Superoxides | 2002 |
Differential alteration of vascular reactivity in rabbit aorta with modest elevation of serum cholesterol.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Carbachol; Cholesterol; Cholesterol, Dietary; Dinoprost; Hypercholesterolemia; In Vitro Techniques; Isoproterenol; Male; Nitroprusside; Norepinephrine; Phorbol 12,13-Dibutyrate; Rabbits; Serotonin; Time Factors; Vasoconstriction; Vasodilation | 1990 |
The hypertensive response to vasopressor agents stimulates the release of thromboxane A2 in hypercholesterolaemic rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Epoprostenol; Ergonovine; Hypercholesterolemia; Nitroglycerin; Norepinephrine; Rabbits; Thromboxane A2; Thromboxane B2; Verapamil | 1989 |
[The release of thromboxane A2 and prostacyclin due to vasoactive agents in hypercholesterolemic rabbits].
Topics: Angiotensin II; Animals; Blood Pressure; Epoprostenol; Ergonovine; Hypercholesterolemia; Nitroglycerin; Norepinephrine; Rabbits; Thromboxane A2; Verapamil | 1986 |
[Pharmacologic study of 4 fractions of Soja lipexidase].
Topics: Angiotensin II; Animals; Drug Antagonism; Glycine max; Hypercholesterolemia; Hyperlipidemias; Hypothermia; Hypoxia; Male; Oxygenases; Plants, Edible; Rats; Surface-Active Agents; Trypsin Inhibitors | 1971 |